Amyloidosis is a heterogeneous group of disorders characterized by extracellular deposition of amorphous proteinaceous material in various tissues.
Amyloidosis of bladder is of significant clinical interest to the urologist because of its presentation as urothelial cancer. Transurethral resection and histology examination is essential to exclude malignancy and to establish the benign nature of amyloidosis. Apart from managing the localized bladder amyloidosis, it is important to exclude systemic amyloidosis. Here in we describe two cases of localized, primary amyloidosis and discuss briefly their management and follow-up.
Written by:
Bardapure M, Namasivayam SK, Rogawski K. Are you the author?
Department of Urology, Huddersfield Royal Infirmary, Lindley, Huddersfield, HD3 3EA, UK.
Reference: Urol Ann. 2013 Oct;5(4):309-11.
doi: 10.4103/0974-7796.120310
PubMed Abstract
PMID: 24311920
UroToday.com Bladder Cancer Section
